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FGFBlood progenitors arise from a pool of pluripotential cells (“hemangioblasts”) within the Drosophila
embryonic mesoderm. The fact that the cardiogenic mesoderm consists of only a small number of highly
stereotypically patterned cells that can be queried individually regarding their gene expression in normal and
mutant embryos is one of the signiﬁcant advantages that Drosophila offers to dissect the mechanism
specifying the fate of these cells. We show in this paper that the expression of the Notch ligand Delta (Dl)
reveals segmentally reiterated mesodermal clusters (“cardiogenic clusters”) that constitute the cardiogenic
mesoderm. These clusters give rise to cardioblasts, blood progenitors and nephrocytes. Cardioblasts emerging
from the cardiogenic clusters accumulate high levels of Dl, which is required to prevent more cells from
adopting the cardioblast fate. In embryos lacking Dl function, all cells of the cardiogenic clusters become
cardioblasts, and blood progenitors are lacking. Concomitant activation of the Mitogen Activated Protein
Kinase (MAPK) pathway by Epidermal Growth Factor Receptor (EGFR) and Fibroblast Growth Factor Receptor
(FGFR) is required for the speciﬁcation and maintenance of the cardiogenic mesoderm; in addition, the
spatially restricted localization of some of the FGFR ligands may be instrumental in controlling the spatial
restriction of the Dl ligand to presumptive cardioblasts.igorian).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Cells of the blood, vascular and excretory system are develop-
mentally related in all animals. In vertebrates, the lateral plate
mesoderm gives rise to the progenitor cells of endothelia and blood
cells (hemangioblasts) (Al-Adhami and Kunz, 1977; Cofﬁn and Poole,
1988; Medvinsky et al., 1993; Cleaver et al., 1997; Eichmann et al.,
1998; Gering et al., 1998; Crosier et al., 2002; Hartenstein, 2006;
Xiong, 2008; Bertrand and Traver, 2009). Adjacent to the lateral plate
is the intermediate mesoderm that produces the nephrocytes of the
excretory system (pro-, meso-, metanephros). Hemangioblasts leave
the lateral plate and migrate dorsally to differentiate into a system of
endothelial tubes that pioneer the major blood vessels, including the
aorta and cardinal veins. Progenitors of adult blood cells are speciﬁed
within the walls of these primitive vessels; they are budded off into
the vessel lumen and eventually settle in the blood forming organs
(“deﬁnitive hematopoiesis”). In addition to these adult blood
progenitors, blood cells populating the embryo are formed within
the ventral blood islands and yolk sac (“primitive hematopoiesis”).
In Drosophila, progenitors of the blood, vascular and excretory
system originate from a lateral domain of the mesoderm, calledthe cardiogenic mesoderm (Hartenstein et al., 1992; Bate, 1993;
Rugendorff et al., 1994; Zaffran et al., 2002; Mandal et al., 2004). The
cardiogenic mesoderm is comprised of ten paired, segmentally
repeated clusters of cells, three thoracic and seven abdominal clusters.
Each cluster gives rise to a set of cardioblasts which assemble into a
contractile, myo-endothelial tube, the dorsal vessel (or “heart”) of the
ﬂy (Bodmer et al., 1997). In addition, the abdominal cardiogenic
mesoderm produces groups of nephrocytes (“pericardial nephro-
cytes”) which form part of the excretory system (Crossley, 1985;
Rugendorff et al., 1994; Ward and Skeath, 2000). Progenitors of adult
blood cells (prohemocytes) arise within the three thoracic cardio-
genic mesodermal clusters. These prohemocytes aggregate together
and form the so-called lymph gland that ﬂanks the anterior tip of the
dorsal vessel in the late embryo and larva (Rugendorff et al., 1994;
Mandal et al., 2004). Prohemocytes proliferate during larval stages
and are released into the hemocoel (the body cavity of the insect)
during metamorphosis (Lanot et al., 2001; unpublished data). Aside
from this late embryonic/postembryonic “deﬁnitive” phase of blood
development, there exists, just as in vertebrates, an early, “primitive”
phase of blood formation that takes place in themesoderm of the head
of the early embryo (Tepass et al., 1994; Holz et al., 2003; Evans et al.,
2003; de Velasco et al., 2006).
Molecular factors specifying cells of the blood-vascular and
nephrocyte lineages, as well as the signaling mechanisms controlling
the expression of these factors, are highly conserved among all
Fig. 1. Partitioning of the mesoderm by the Wingless (Wg) and Decapentaplegic (Dpp)
signals. cm, cardiogenic mesoderm; fb, fat body sm, somatic mesoderm; vm, visceral
mesoderm. Combined Notch and MAPK activity deﬁnes smaller clusters (“myogenic
and cardiogenic clusters”) in the somatic and cardiogenic mesoderm (light colored
ovals).
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Hartenstein and Mandal, 2006; Hartenstein, 2006; Crozatier and
Meister, 2007; Martinez-Agosto et al., 2007). Hemangioblasts of the
vertebrate lateral plate and Drosophila cardiogenic mesoderm are
induced from naive mesoderm by several signaling pathways that
include Bone morphogenetic protein (BMP)/Decapentaplegic (Dpp)
and ﬁbroblast growth factor (FGF)/Heartless (Htl). The activity of
these signals is required for upregulating blood and vascular/heart
determinants such as the GATA factors/Serpent (Srp) or Nkx2.5/
Tinman (Tin), and thereby speciﬁes and maintains the fate of
hemangioblasts (Baron, 2003; 2005; Crosier et al., 2002; Maeno,
2003). Notch signaling plays an important role in specifying blood
progenitors from the bi-potential (vascular/blood) hemangioblasts.
Thus, Notch activation in the endothelial hemangioblasts of vertebrate
embryos results in the expression of blood cell determinants such as
GATA2, stem cell leukemia (SCL) and acutemyeloid leukemia 1 (AML1),
placing the Notch signaling pathway high up in the molecular network
initiating hematopoiesis (Kumano et al., 2003; Hadland et al., 2004;
Robert-Moreno et al., 2005; Burns et al., 2005). Again, the same switch
between vascular cells and blood progenitors is under the control of
Notch signaling in Drosophila: loss of Notch activity during the phase
when the fate of cardiogenic mesodermal cells is speciﬁed results in
the absence of blood progenitors and an excess of cardioblasts (Mandal
et al., 2004). Whereas the important role of Notch signaling for blood
progenitor fate in Drosophila, as in vertebrates, is well established, the
signal that activates the Notch receptor, and the mechanism by which
the signal itself becomes active in the restricted spatial pattern that
guaranteeing the proper number and distribution of blood progenitors,
has not so far been elucidated. In this paper we address these questions
in Drosophila, taking advantage of the fact that the Drosophila
cardiogenic mesoderm is comprised of only a few cells, many of
which can be individually marked by molecular reagents.
The Drosophila mesoderm arises as a single cell layer during
gastrulation. Subsequently, mesodermal cells undergo two parasyn-
chronous mitotic divisions (Campos-Ortega and Hartenstein, 1985;
Bate, 1993). During this early phase, genes which later demarcate
speciﬁc mesodermal lineages, such as tin orMyocyte Enhancer Factor 2
(Mef2), are expressed in the entire mesoderm (Azpiazu and Frasch,
1993; Bodmer, 1993; Lilly et al., 1994; Taylor et al., 1995), suggesting
that mesodermal cells are equipotent and have not yet split up into
discrete lineages. The speciﬁcation of different lineages is initiated by a
series of signaling steps,which include theWingless (Wg), Notch, Dpp,
Epidermal Growth Factor (EGF), and FGF pathways (Bate, 1993;
Zaffran et al., 2002; Hartenstein, 2006). As a result, the mesoderm of
each segment becomes subdivided into four quadrants (Borkowski et
al., 1995; Riechmann et al., 1997;Mandal et al., 2004;Martinez-Agosto
et al., 2007; Fig. 1): high levels of Tin expression, dependent on both
ﬁbroblast growth factor receptor (FGFR) activity and an ectodermally
derived Dpp signal, deﬁne the dorsal mesoderm. The anterior, Wg-
positive dorsal mesoderm forms the cardiogenic mesoderm while the
Wg-negative posterior dorsal mesoderm becomes the visceral meso-
derm. The two ventral quadrants give rise to the somatic musculature
(Wg-positive, anteriorly) and fat body (Wg-negative, posteriorly). The
expression of cell type speciﬁc genes at this stage indicates that fat
body, somatic mesoderm and visceral mesoderm have become
molecularly distinct entities. By contrast, the cardiogenic mesoderm
at this stage still represents a mixed population of cells with different
fates. These fates include cardioblasts, pericardial nephrocytes and at
least two other, different types of “pericardial” cells (Even-skipped
(Eve) and Tin-positive pericardial cells), blood progenitors, and dorsal
muscle cells (Ward and Skeath, 2000; Knirr and Frasch, 2001).
Cell–cell interactions depending on Notch, EGF and FGF signaling
single out from within the Wg-positive somatic and cardiogenic
mesoderm 19 small clusters of cells, called C1-C19 (Carmena et al.,
1995; 1998; 2002; Buff et al., 1998; Fig. 5A). These are revealed by the
expression of the bHLH transcription factor Lethal of scute (L'sc), aswell as the expression of phosphorylated Mitogen Activated Protein
Kinase (pMAPK), a reporter for EGF and FGF signaling activity.
Clusters of the somatic mesoderm (C1, C3–C13, C17) give rise to the
so-called muscle founder cells, which act as pioneers to specify the
pattern of somatic muscles (Bate, 1993; Carmena et al., 1995). While
C18 and C19 have not been as thoroughly characterized as the rest, it
is known that C18 expresses higher levels of L'sc in thoracic than in
the abdominal segments, while C19 is found only in thoracic segments
(Carmena et al., 1995). We show, in this study, that the dorsal clusters
(C2; C14–C16) constitute the deﬁnitive cardiogenic mesoderm that
gives rise to cardioblasts, blood progenitors and nephrocytes. As the
cardioblasts emerge they accumulate high levels of the Notch ligand
Dl, which is required to restrict the number of cells adopting the
cardioblast fate. Loss of Dl converts all cells of the cardiogenic
mesoderm into cardioblasts. Activation of theMAPK pathway by EGFR
and FGFR is required for the speciﬁcation and maintenance of the
cardiogenic mesoderm, and is also likely to be involved in the spatial
restriction of the Dl ligand to cardioblasts.
Materials and methods
Fly stocks
Delta9p, Df(1)scB57, dppH46, dpp-lacZ, EGFRf2, htlAB42, spitz-lacZ,
UAS-EGFR DN, UAS-htl Constitutively activated, UAS-RasV12, UAS-dpp,
UAS-wg, wgCX4 (Bloomington Stock Center). 12X Su(H)-lacZ (con-
struct with 12 Su(H) binding sites upstream of a lacZ; Go et al.,
1998),Mef2-gal4 (Ranganayakulu et al. 1996), UAS-EGFR activated #3
(UAS-λ top 4.4; Queenan et al. 1997, kindly gifted by T. Schupbach),
UAS-l'sc (Carmena et al. 1995), UAS-l'sc Rnai (NIG: Japan). htl-lacZ
(Stathopoulos et al. 2004), thisbe-lacZ #2 (Stathopoulos et al. 2004),
Df(2R)ths238 and Df(2R)pyr36 (Kadam et al. 2009), wg-lacZ (NIG:
Japan N755).
Antibodies
Antibodies used for immunohistochemistry include: α-mouse-β-
galactosidase (1:50) (Promega), α-rabbit-β-galactosidase (1:2500)
(Cappel), α-guinea pig-delta (1:1000)(Huppert et al., 1997), α-rat-
EGFR (1:500) (kindly gifted by B. Shilo), α-rat-L'sc (1:800)(Martin-
Bermudo et al., 1991, kindly gifted by A. Carmena), α-Rabbit-Mef2
(1:1500) (Nguyen et al., 1994), α-rabbit-Odd (1:500) (Ward and
Skeath, 2000), α-Mouse-Pericardin (1:3) (Developmental Hybridoma
Bank), α-Mouse-pERK (pMAPK) (1:50) (Sigma), α-Rabbit-Tinman
(1:800) (Venkatesh et al., 2000).
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Regular
Flies were placed on fruit juice plates for overnight egg laying
collection. Embryos/eggs were treated with 100% bleach for 6 minutes
and then washed with water. Embryos were then ﬁxed in a solution of
3.5 ml PEMS, 3.5 ml Heptane and 1.5 mL 37% Formaldehyde for
35 minutes. PEMS (pH 7) is a solution consisting of 100 mL PIPES
(0.2 M solution, pH 7), 90 mL of Deionized water, 8 mL EGTA (0.05 M
solution) and 2 mL MgSo4 (0.1 M solution). The bottom phase of the
solution (PEMS)was then removed andMeOHwas added in an amount
comparable to the PEMS removed. Vial was shaken vigorously and
settled embryos were collected and stored in EtOH at−20 °C till use.
Embryo ﬁxation for pMAPK staining
Above ﬁxation technique was carried out with the following
modiﬁcation: 10 mM of Sodium Orthovanadate and 1:500 of 30%
hydrogen peroxide (H2O2) were added to the PEMS solution. Also, for
pMAPK staining, ﬁxed embryos were stained immediately with
pMAPK antibody.
Staging of embryos
We followed the system of stages introduced by Campos-Ortega
and Hartenstein (1985). To recognize smaller steps within stages 11
(late extended germband) and 12 (germband retraction), each of
which lasts for about 2 h, we deﬁned morphological criteria that are
easily recognizable without speciﬁc markers. Stages 11 and 12 were
subdivided into three roughly equal intervals called 11A (early 11),
11B (mid 11), 11C (late 11), 12A (early 12), 12B (mid 12) and 12C
(late 12). Deﬁning criteria for these stages:
– 11A: Tracheal pits start to form and progress to hemispherical
invaginations.
– 11B: Tracheal pits form vertical slits; salivary placode can be
distinguished as a thickened part of the ventral ectoderm of the
labial segment.
– 11C: Salivary placode starts to invaginate.
– 12A: Salivary placode invaginates to form a straight, vertical, tube-
shaped primordium. Germband starts to retract (83% to 75%).
– 12B: Salivary primordium elongates and is bent posteriorly at
posterior tip. Germband retracts to 50%.
– 12C: Stage of rapid germband retraction (50%–0%).
Each of these stages can be further subdivided into intervals of 10–
15 minutes length, each deﬁned by clear (if subtle) morphological
changes (V. Hartenstein, unpublished data).
Immunohistochemistry
Regular
Samples were washed with 0.1% PBT three times for 15 minutes
each at room temperature while rotating. Samples were then blocked
for 30 minutes in a solution of 10% NGS made in 0.1% PBT. Samples
then placed in 1° antibody solutionmade in 10% NGS and left to rotate
overnight at 4 °C. Samples were then washed and blocked as des-
cribed above and placed in a 2° antibody conjugated to a ﬂuorescent
marker. Samples were left in 2° antibody to rotate overnight at 4 °C.
Samples were then washed as described above and mounted in
Vectashield (Vector Laboratories) containing a 1:500 concentration of
Toto-3-iodide (Invitrogen).
L'sc antibody staining
Used Perkin-Elmer Life Sciences Renaissance Tyramide Signal
Ampliﬁcation Biotin System (Catalog #NEL700A).In situ hybridization
L'sc RNA probe synthesis
L'sc clone (RE59335) was received from Berkeley Drosophila
Genome Project (BDGP). Plasmid was digested with appropriate
restriction enzyme. Then treated with 300 μL of TE or water. Phenol/
chloroform extraction was carried out by adding 150 μL of each agent
and then centrifuging DNA twice at 12,000 rpm for 5 minutes each.
The third time 300 μL of chloroformwas added and centrifugationwas
carried out as described above. The upper phase was saved each time
and moved to a new centrifuge tube. After ﬁnal spin, 270 μL of the
upper phase was transferred to a new tube and 27 μL of 3 M sodium
acetate and 210 μL of isopropanol was added. Sample was mixed well
between addition of each agent. Sample was then incubated for
20 minutes at room temperature. The sample was then spun at
15,000 rpm for 15 minutes. The supernatant was discarded and the
pellet was washed with 500 μL of 70% EtOH. Sample was spun again
for 5 minutes at 15,000 rpm. The supernatantwas again discarded and
the pellet was allowed to air dry for 10 minutes. Pellet was then
dissolved in 16 μL TE. Probe was then synthesized by placing 1 μg of
prepared template DNA with 4 μL of 5X transcription buffer, 2 μL of
100 mM DTT, 2 μL Dig-NTP mix, 2 μL RNA Polymerase, 1 μL RNase
inhibitor, 1 μL50 mM MgCl2 and ﬁlling up to 20 μL with ddH2O. The
mixture was incubated for 2 h at 37 °C. 2 μL of DNaseI (RNase free)
was then added and sample was incubated for an additional
25 minutes at 37 °C. 80 μL of RNase free water was then added. The
RNA probe was then puriﬁed using a Qiagen RNeasy Kit (Cat #74106).
Protocol from kit was used to purify RNA. Ethanol precipitation was
then carried out by adding 6 μL of 3 M sodium acetate and 15 μL of
100% EtOH to the sample and leaving it at either−20 °C overnight or
at −80 °C for 30 minutes. Sample was then spun at 15,000 rpm for
15 minutes at 4 °C. Supernatant was discarded and pellet was rinsed
with 300 μL of 70% EtOH. Sample was spun again at 15,000 rpm for
5 minutes at 4 °C. EtOH was then discarded and RNA was dissolved in
40 μL of RNAse free water. The quality of the probe was checked by
electrophoresis and 120 μL of hybridization buffer was added to it
before it was stored at −20 °C.
Embryo preparation and in situ hybridization
Embryos ﬁxed as stated above, except in 4% Formaldehyde (EM
grade)/PBS with same amount of heptane for 30–45 minutes.
Embryos are stored in MeOH. To rehydrate, embryos were treated
with 75%, 50%, and 25% MeOH made in PBS for 5 minutes each.
Embryos were then washed three times for 5 minutes each in 0.1%
PBST. Embryos were then treated with 300 μL of 10 μg/mL proteinase
K for 4 minutes (did not rotate). Proteinase K was then discarded and
glycine (2 mg/ml) made in PBST added twice for 1 minute each.
Sample was then ﬁxed again with 4% EM Grade Formaldehyde for
5 minutes. Sample then washed with PBST 5 times for 5 minutes each.
Embryos were then pre-hybridized by adding a 1:1 solution of pre-
hybridization buffer and PBST to them for 5 minutes. Embryos were
then treated with Pre-hybridization buffer alone for 5 minutes.
Embryos were then rinsed with 300 μL of hybridization buffer before
300 μL of hybridization buffer was added and embryos were
incubated for more than 1 h at 60 °C. To carry out hybridization,
diluted 16 μL of labeled probe with 100 μL hybridization buffer. The
diluted probe was heated at 80 °C for 10 minutes and then chilled on
ice. Extra solution was removed from tube containing embryos,
leaving only 100 μL of hybridization buffer. Denatured probe was then
added to the tube and hybridization was allowed to ensue at 60 °C
overnight. The embryos are then washed with preheated (60°)
washing reagents. Washed initially with 50% formamide and 2× SSCT
twice for 20 minutes each at 60 °C. Followedbywashing twicewith 2×
SSCT for 10 minutes each. Finally, washed twice with 0.2× SSCT for
30 minutes each. Immunoreaction was then carried out. Embryos
were rinsedwith PBST. Embryoswere then blockedwith 0.2% blocking
Fig. 2. Delta (Dl) activity is localized and required in the cardiogenic mesoderm for the
speciﬁcation of blood progenitors and pericardial nephrocytes. A–F: lateral views of
stage 13 (A–B, E–F) and 14 (C–D) embryos. Left column (A, C, E) are wild type, right
column (B, D, F) Dlmutants. Upper panels (A–B) are labeled with anti-Dl (green), anti-
Mef2 (red) and Sytox (blue). Mef2 labels both cardioblasts (cb) and somatic muscle
cells (sm). Middle panels (C–D) are labeled with anti-Tinman (Tin; red) and anti-
Delta (green). Tin labels cardioblasts and Tin positive pericardial cells (tpc). Lower
panels (E, F) show labeling with Sytox (blue) and anti-Odd skipped (red), which labels
the lymph gland progenitors (lg) and the Odd positive pericardial nephrocytes (pcn). Dl
is expressed in cardioblasts in wild type embryos (A). In the absence of Dl (B, D),
cardioblasts are strongly increased in number, while Odd-positive pericardial
nephrocytes and lymph gland blood progenitors are missing (F). G–I: High
magniﬁcation of the cardiogenic mesoderm of a stage 13 wild-type embryo, showing
Dl expression in the cardioblasts (G), and expression of a lacZ gene found downstream
of 12 Suppressor of hairless [Su(H)] binding sites [reporter for Notch activity (N. rep.)]
in the adjacent pericardial nephrocytes and lymph gland (H, I). Other abbreviations: de
Odd-positive dorsal ectoderm cells Bars: 25 μm (A–D); 10 μm (E–G).
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were then placed in anti-DIG antibody made in 0.2% blocking reagent
overnight at 4 °C or for 2 h at room temperature. Antibody was then
washed 6 times with PBST for 10 minutes each. Embryos then washed
twice with AP buffer (with 0.01% Tween20) for 5 minutes each.
Finally, to stain NBT/BCIP tablets were dissolved in water and 500 μL
of it was added to the embryos. Signal was then developed in the dark.
To stop the reaction, embryos were washed 5 times with PBST (short
washes initially, followed by a ﬁnal 5 minute wash). To remove
background, PBST containing 1% tween20 was added to embryos
overnight at room temperature. Embryos were then rinsed and
mounted in 50% glycerol/PBS initially and ﬁnally in 100% glycerol.
Solutions included hybridization buffer (20 mL Formamide, 10 mL
of 20× SSC, 40 mg RNA (ribosomal), 200 μL 10 mg/mL Heparin, 200 μL
20%Tween20 andddH20 (autoclaved) up to 40 mL), Pre-Hybridization
buffer (20 mL Formamide, 10 mL of 20× SSC, 200 μL 10 mg/mL
Heparin, 200 μL 20% Tween20 and ddH2O (autoclaved) up to 40 mL),
20× SSC (175.3 g NaCl and 88.2 g SodiumCitrate in 1 L of ddH2Owith a
pH of 7.0), AP buffer (5 mL Tris–HCl (pH 9.5), 1 mL of 5 N NaCl, 2.5 mL
of 1 M MgCl2 and up to 50 mL of ddH2O), AP buffer with Tween20
(added 0.5 μL of 20% Tween20 to each 1 mL of AP buffer), PBST (PBS
containing 0.1% Tween20).
Generation of 3D digital models
Staged Drosophila embryos labeled with anti-Delta and other
markerswere viewed aswholemounts by confocalmicroscopy (Biorad
MRC 1024ES microscope using Biorad Lasersharp version 3.2
software; lenses: 40× oil; 60× oil). Complete series of optical sections
were taken at 1 mm intervals for at least ﬁve individuals per stage.
Tif ﬁles of the confocal stacks were generated using Image J (Abramoff
et al., 2004), and imported into the software package TrakEM2
(Cardona et al., 2010), which allows for efﬁciently segmenting
structures by outlining them or, in case of simple shapes like
nuclei, simply clicking them. We used the built in 3D viewer of
TrakEM2 to generate three dimensional models of the segmented
structures.
Results
Delta signaling within the cardiogenic mesoderm speciﬁes
blood precursor fate
Previous studies had shown that Notch activity is required within
the cardiogenic mesoderm during 8–10 h after egg laying (AEL) for
the correct speciﬁcation of the different cardiogenic lineages,
including cardioblasts (vascular cells), blood progenitors, and peri-
cardial nephrocytes. Speciﬁcally, a high level of Notch activity is
necessary for the speciﬁcation of Odd-skipped (Odd)-positive
pericardial nephrocytes and blood progenitors (Mandal et al., 2004).
Drosophila Notch has two ligands, Dl and Serrate (Ser). To test
which one of these acts in the cardiogenic mesoderm, we analyzed
their loss of function phenotype. Embryos mutant for the Ser gene
did not exhibit any detectable abnormalities among the cell types
formed from the cardiogenic mesoderm (data not shown). On the
other hand, null mutations in Dl caused a complete loss of pericardial
cells and hematopoietic precursors (Fig. 2E–F). In contrast, cardioblast
numbers were dramatically increased, phenocopying the Notch
mutant phenotype (Mandal et al., 2004; Fig. 2A–D). Two markers,
Mef2 and Tin were used to label cardioblasts. Mef2 in addition to
being found in cardioblasts is also found in somatic muscle cells
(Fig. 2A). Meanwhile Tin is expressed in cardioblasts as well as in the
Tin positive pericardial cells (Fig. 2C). Dl mutants labeled with either
marker showed an increase in the number of cells being labeled in
comparison to their WT counterparts (Fig. 2B, D).A construct with 12× Su(H) binding sites upstream of a lacZ was
used to report activated Notch signaling (Go et al., 1998). This in
conjunction with Dl expression studies provided further insight into
the Notch/Dl-dependent signaling step acting in the cardiogenic
mesoderm. As shown in the following section, in more detail,
expression of Dl is widespread and dynamic in the mesoderm around
the time when the fate of cardiogenic cells is speciﬁed (stage 12; 7–
9 h AEL). Toward the end of this period, expression of Dl becomes
restricted to the cardioblasts, where it stays on until stage 14
(approximately 11 h AEL; Fig. 2G). 12× Su(H)-lacZ is also expressed
in the cardiogenic mesoderm of stage 12–14 embryos, but becomes
restricted to the pericardial cells and blood progenitors ﬂanking
the Dl expressing cardioblasts (Fig. 2H–I). These ﬁndings indicate
that the expression of Dl in the cardiogenic mesoderm provides the
signal controlling the proper balance between the different cardio-
genic lineages.
Origin and morphogenesis of the cardiogenic mesoderm
To learn more about the signaling mechanism that distinguishes
between the different cardiogenic fates we next carried out a detailed
analysis of the dynamic changes that occur in cell position and
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to the expression pattern of Dl, as well as other factors known to be
involved in the control of Dl, notably the proneural gene l'sc, and
members of the EGF and FGF signaling pathways.
The different cardiogenic lineages split from each other during
embryonic stage 12 (7–8.5 h AEL). Prior to the beginning of this phase,
the cardiogenic mesoderm, deﬁned by the expression of Tin, forms
segmentally reiterated, elongated clusters of approximately 30–35
cells each (“early cardiogenic mesoderm”; Fig. 3A, Q). This number
increases to about 60 cells at the end of stage 12 (Fig. 3N, T), following
the fourth round of mitosis (Bate, 1993) that takes place during this
time period (Fig. 3F, L, O). Based on cell size/shape and the expression
levels of Dl, one can distinguish a dorsal and ventral subdomain
within the cardiogenicmesoderm of the stage 12 embryos. Cells of the
ventral domain are small and express moderate levels of Dl and Tin;
dorsally, we see larger cells, expressing higher levels of Tin (Fig. 3E, R).
Dl expression is highly dynamic in the dorsal domain; at most time
points during stage 12, we see an anterior and posterior cluster of
strongly Dl-positive cells, ﬂanking a central cluster with lower Dl
levels (Fig. 3E', R; schematically shown in Fig. 4). This central cluster
expresses Even-skipped (Eve; Fig. 3F'; Fig. 4). As a matter of fact, Eve-
expression deﬁnes a dorso-central cluster already in the early
cardiogenic mesoderm (Fig. 3B, C and see below); from within this
cluster, the pair of Eve-positive pericardial cells is speciﬁed (Carmena
et al., 1998). The later Eve-positive/low-Dl dorso-central cluster gives
rise to a dorsal muscle. The anterior and posterior, high-Dl clusters
form the “deﬁnitive” cardiogenic mesoderm (cmd in Fig. 3); as
detailed below, they will give rise to the cardioblasts of the dorsal
vessel and the Odd-positive blood progenitors and pericardial
nephrocytes. The ventral domain showing low levels of Tin and Dl
(colored green in Fig. 3Q–T) contribute to the dorsal musculature; a
number of these cells seem to undergo apoptosis at a later stage (data
not shown).
Individual lineages derived from the cardiogenic mesoderm
segregate from each other and begin to differentiate during the
second half of stage 12 (12B and 12C; 8–9 h AEL). Morphogenetic
events that unfold during this time interval are complex; they include
cell division (the fourth mesodermal mitosis), cell movements within
each segment, as well as cell movements occurring as part of germ
band retraction. The anterior and posterior high-Dl cluster of each
segment move closer together (compare Fig. 3E/E' with 3K/K'), while
the central, low-Dl cluster moves “out of the way,”migrating laterally
and ventrally (compare Fig. 3F/F' with Fig. 3L/L'). During the phase
when this cell rearrangement takes place andmost cells undergo their
ﬁnal (4th) mitosis, Dl expression becomes restricted to the cardio-
blasts. In the thoracic segments, each of the high-Dl clusters forms two
cardioblasts (Fig. 3K/K', Fig. 3N/N'; Fig. 4). In abdominal segments,
three cardioblasts arise per cluster. However, only two cells of each
abdominal cluster maintain a high level of Dl and Tin. The third cell
down-regulates these genes and expresses Seven-up (Svp; Gajewski
et al., 2000; Ward and Skeath, 2000). Expression of Svp is already
apparent during the beginning of stage 12when the high-Dl cells form
a separate anterior and posterior cluster in each segment (Fig. 3G).
Like most other cells within the high-Dl clusters, the Svp-positive cells
also divide once, forming an anterior and posterior pair in each
segment (Fig. 3G, H/H'). When high-Dl clusters are pushed together
during germ band retraction, the posterior Svp-positive pair of a given
segment meets the anterior Svp-positive pair of the posteriorly
adjacent segment (Fig. 3M/M'; 3P/P'; schematically shown in Fig. 4).
The dorsal sibling of each Svp-positive pair will become a cardioblast;
the ventral sibling a pericardial nephrocyte (Ward and Skeath, 2000;
see below). In this manner, the pattern of alternating sets of four Tin/
Dl-positive and two Svp-positive cardioblasts characteristic of the
abdominal dorsal vessel is generated (Fig. 3P/P').
Pericardial nephrocytes and blood progenitors also become
discernable by size, position and expression of the gene odd by latestage 12. Based on our detailed reconstructions of embryos expressing
odd in combination with tin or Dl we propose that nephrocytes and
blood progenitors derive from the high-Dl clusters (Figs. 3, 4).
Abdominal segments produce four pairs of nephrocytes; two pairs are
svp-positive (siblings of the Svp-positive cardioblasts; see above), the
other two are Svp-negative. Meanwhile, the three thoracic segments
each give rise to approximately eight to ten pairs of blood progenitors,
all of which are Svp-negative. Similar to the abdominal nephrocytes, a
considerable fraction of the blood progenitors are also siblings of the
cardioblasts (Mandal et al., 2004). What accounts for the higher
number per segment of blood progenitors vs. nephrocytes? The high-
Dl clusters of the thoracic segments of stage 12B embryos (prior to
separation of cardioblasts and blood progenitors) are not signiﬁcantly
larger than their abdominal counterparts (Fig. 3F/F'; Fig. 4). However,
the fraction of cells undergoing a fourth round ofmitosis appears to be
higher in the thoracic segments than the abdominal segments
(Fig. 3F/F'), which may be in part responsible for the higher number
of blood progenitors. A second contributing factor may be the fact that
the two pairs of cells that express Svp and produce cardioblasts and
nephrocytes in the abdominal segments generate only blood
progenitors in the thoracic segments.
To sum up, we show that two high-Dl clusters located within the
lateral mesoderm of the stage 11/early 12 embryo, called “cardiogenic
clusters” from hereon onward, represent the deﬁnitive cardiogenic
mesoderm fromwhich cardioblasts, blood progenitors and pericardial
nephrocytes are derived. Notch/Dl dependent interactions within the
cardiogenic clusters separate these cell types, whereby the signal Dl
becomes restricted to cardioblasts, and high levels of Notch activity
appear in the adjacent blood progenitors/nephrocytes.
The cardiogenic clusters are deﬁned by the co-expression of Dl, l'sc and
activated MAPK
Careful mapping studies of themesoderm, using a probe for the l'sc
gene, had revealed nineteen clusters (C1–C19) deﬁned by (transient-
ly) high levels of L'sc. (Carmena et al., 1995; Fig. 5A). These same
clusters also co-express pMAPK, a reporter for MAPK signaling. We
can identify two of these clusters, C14 and C16, as the high-Dl,
deﬁnitive cardiogenic mesoderm described in the previous section. C2
and C15 correspond to the Eve-positive clusters. Thus, in situ and
antibody stainings revealed a cluster (C2) of L'sc positive cells in the
center of the early cardiogenic mesoderm of the stage 11 embryos
(Fig. 5B), and three clusters covering the deﬁnitive cardiogenic
mesoderm. The latter three included the two clusters (C14, C16) and
the late Eve-cluster (C15) of the early stage 12 embryo (Fig. 5C). Using
double labeling with an antibody against Dl and pMAPKwe conﬁrmed
that the same clusters also express pMAPK during stage 11 (C2) and
stage 12 (C14–16; Fig. 5D, E). These ﬁndings suggest that both the
MAPK pathway as well as L'sc may act in the cardiogenic mesoderm to
maintain/focus the expression of Dl, and thereby provide necessary
input for the development of pericardial nephrocytes and blood
progenitors. To test this hypothesis we carried out loss and gain of
function studies for members of both pathways.
MAPK activity, mediated by the EGF and FGF pathways, is required for
the speciﬁcation of blood progenitors and pericardial nephrocytes
Past studies had already shown that Ras, a member of the MAPK
pathway, is capable of activating Dl expression. Constitutive activation
of Ras leads to a persistence of Dl expression in the clusters C2 and C15
of L'sc positive cells present in the cardiogenic mesoderm (Carmena
et al. 1998; 2002). We wanted to investigate whether this pathway is
also active in the cardiogenic mesoderm, that is, clusters C14 and C16.
Overexpression of a constitutively active form of Ras (RasV12) using a
Mef2-gal4 driver, expressed globally in the somatic and cardiogenic
mesoderm (Taylor et al., 1995; Ranganayakulu et al., 1996) resulted in
Fig. 3.Morphogenesis and cell fate in the cardiogenic mesoderm. Photographic panels show lateral views of embryos at stages indicated to the left (for subdivision of stage 12, see
Materials and methods). Each panel shows several consecutive segments of the mesoderm, labeled by anti-Dl (green); segments are indicated at bottom of panels (T1–T3: thoracic
segments 1–3; A1–A3: abdominal segments 1–3). In most cases, a lowmagniﬁcation view and a highmagniﬁcation view of the same specimen are shown in consecutive panels (e.g.,
E and E'; F and F'). For stage 12A, panel C presents a view of the cardiogenic mesoderm, and panel D shows a more medial section corresponding to the visceral mesoderm. Similarly,
for stage 12B, E/E' and F/F' present the cardiogenic mesoderm, I and J the visceral mesoderm. In all panels of left column, the second marker used besides anti-Dl is anti-Tinman (Tin;
red) which labels the cardiogenic mesoderm. Embryos shown in the panels of the second column, as well as panels C and D of the third column, were labeled with anti-
Phosphohistone3 (PH3), a marker for mitotic cells, as well as anti-Even-skipped (Eve; blue). In the third column, Seven-up (Svp)-positive cells are labeled by svp-Gal4NUAS-GFP
(red). In these embryos, the lumen of the segmental tracheae and the demarcating segmental boundaries, are rendered in blue. Panels on the right (Q–T) show 3D digital models of
the cardiogenic mesoderm at stages indicated at the top of each panel. Individual cells of cardiogenic mesoderm are shown as colored spheres, with colors representing different
transient and deﬁnitive cell fates: cb cardioblasts (red in S–T); cmd deﬁnitive cardiogenic mesoderm (orange in Q; comprises anterior (a) and posterior (p) high-Dl cluster); cme
early cardiogenic mesoderm (light orange/green in Q); cbsvp Svp-positive cardioblasts (pink in T); Dl- low-Dl clusters (pale yellow in R); eve-pc Even skipped-positive pericardial
cells (brown in R-T); lg blood progenitors of the lymph gland (magenta in T); pcn pericardial nephrocytes (magenta in T); pre-lg/pcn precursors of blood progenitors and pericardial
nephrocytes (yellow in S); vme early visceral mesoderm (blue in Q); vml late visceral mesoderm (cyan and dark blue in R–T, corresponding to Tin-positive and Tin-negative late
visceral mesoderm cells, respectively). Other abbreviations: dt, dorsal tracheal branch; dlt, dorsal longitudinal trunk of the trachea; tp, tracheal pit; Bars: 25 μm (A–P); 10 μm (E', F',
H'; K'–P').
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Fig. 3 (continued).
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and pericardial nephrocytes were also increased in number. In this
experiment, high levels of Dl expression were also seen in Mef2
positive muscle cells, whereas inWT embryos no such expression was
apparent (data not shown).
Ras is a downstream activator of both the EGF and FGF receptor
tyrosine kinase pathways. In order to determine which of these was
acting in the cardiogenic mesoderm, we carried out gain and loss of
function studies for both the EGFR [Drosophila homolog: faint little ball
(ﬂb)] and FGFR [Drosophila homolog: heartless (htl)] pathways. Mef2-
Gal4-driven expression of a constitutively active FGFR construct
(Fig. 6C) or EGFR construct (not shown) mimicked the phenotype of
Ras expression, in terms of a strongly increased number of bloodprogenitors/nephrocytes and cardioblasts. EGFR loss of function
mutants showed a highly reduced level of Dl in the entire mesoderm
of stage 11/12 embryos (Fig. 6K). Labeling of late mutant embryos
with anti-Odd, anti-Pericardin or anti-Mef2 demonstrated that blood
progenitors, nephrocytes and cardioblasts were virtually absent in
EGFR mutants (Fig. 6E, H). Since in other tissues (Kurada and White,
1998; Protzer et al., 2008), EGFR is an important factor for cell
survival, we also carried out anti-caspase staining to monitor cell
death in the cardiogenic mesoderm. Signiﬁcant amounts of cell death
were seen in the cardiogenic mesoderm of stage 11/12 EGFR loss of
function mutants (Fig. 6F). These data support the idea that EGFR
activity is required for the maintenance of Dl expression and survival
of the cardiogenic mesoderm.
Fig. 4. Speciﬁcation of different cell fates in the cardiogenic mesoderm. Schematic depiction of cardiogenic mesodermal cells (colored spheres) of two adjacent thoracic segments
(left) and two abdominal segments (right) at stage 11 (top), mid stage 12 (middle) and stage 13 (bottom). Different cell types are annotated and colored in the same way as in the
models shown in Fig. 3.
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htl, result in a loss of the dorsal vessel and blood progenitors in late
embryos (Beiman et al., 1996; Gisselbrecht et al., 1996; Shishido et al.,
1997; Mandal et al., 2004). In order to follow the fate of the
cardiogenic mesoderm-derived lineages and Dl expression levels in
embryos lacking FGFR, we did a developmental series of FGFRmutants
labeled with anti-Dl and markers for the different cardiogenic
lineages. FGFR mutant embryos at stages 11 and 12 showed an
abnormally shaped mesoderm; however, metameric clusters of Dl-
positive cells were still visible in the cardiogenic mesoderm (Fig. 6L).
By stage 14, these cells were no longer present (Fig. 6I), indicating that
FGFR signaling, like EGFR, is required for the maintenance of
cardiogenic lineages, but acts at a later phase than EGFR.
The bHLH gene l'sc is required for all cell types derived from the
cardiogenic mesoderm
In order to identify a possible role of l'sc in the cardiogenic
mesoderm, we visualized the cardiogenic lineages in embryos
carrying the deﬁciency Df(1)scB57, which removes the entire
achaete–scute complex (AS-C) (Fig. 7). Homozygous mutants showed
a highly signiﬁcant decrease in the number of pericardial cells and
lymph gland blood progenitors, as well as a small decrease in the
number of cardioblasts. A similar reduction in blood progenitors/
nephrocytes and cardioblasts was observed in embryos where a l'sc-
Rnai was driven with aMef2-Gal4 driver. In neither the deﬁciency nor
the RNAi knock-down experiment did we see a signiﬁcant reduction
in Dl expression in the cardiogenic mesoderm (data not shown).
These ﬁndings indicate that l'sc is required for the appropriate number
of cells within all cardiogenic lineages to form, even though it does not
noticeably alter expression levels of the Notch ligand, Dl.
Controlling the spatial domains of activity of Dl, l'sc, EGFR and FGFR
We next addressed the mechanisms operating upstream of Dl, l'sc
and EGFR/FGFR to set up the spatial domains in which these factors are
active. Previous data had shown that the cardiogenic mesoderm as a
whole depends on the combined presence of high levels of Wg andDpp (Lockwood and Bodmer, 2002). Removal of either of these genes
results in the complete absence of all cardiogenic lineages (Mandal
et al., 2004; Fig. 8A). Similarly, the early cardiogenicmesoderm, which
is strongly positive for Mef2 in wild type (Fig. 6J), does not become
speciﬁed in a wg mutant (Fig. 8E). Both Dpp and Wg act upstream of
Dl; loss of dpp (data not shown) orwg causes the failure to upregulate
Dl or L'sc expression in the mesoderm. Thus, the cardiogenic clusters
C14 and C16 which are strongly Dl-positive and L'sc positive in the
wild type (Fig. 8D) are not apparent in a wg LOF mutant (Fig. 8E). We
conﬁrmed that Wg, detected by an antibody and lacZ reporter
construct, indeed coincides with the cardiogenicmesoderm. Through-
out the early stages of mesodermal development (up to stage 10; 5 h
AEL), Wg is expressed in a stripe-like domain covering the central
part of the ectoderm and the underlying mesoderm of each segment.
The early cardiogenic mesoderm forms the lateral part of the Wg-
positive mesodermal domain (Fig. 8B). At the point when the visceral
mesoderm separates from the cardiogenic mesoderm, the cells within
the latter rearrange, spreading out in the longitudinal axis to cover
almost the entire length of a segment. During early stage 12, the time
of appearance of C14/C16, Wg signal can be detected in these clusters
(Fig. 8C).
The expression of Dl, as well as activation of the MAPK pathway,
becomes highly polarized in presumptive cardioblasts. This polariza-
tion may be important for Dl to exert its proper function, that is, to
modulate Notch activation in the C14/C16 clusters such that the
proper balance of cardioblasts vs. pericardial nephrocytes/blood
progenitors is achieved. We wondered whether a spatially restricted
expression of the ligands and/or receptors of the EGFR and FGFR
pathways may help explain the localized activity of MAPK, which in
turn maintains/polarizes Dl expression. The EGF receptor and FGF
receptor (Htl) are widely expressedwithin the cardiogenic mesoderm
(Fig. 9A–A', C). Likewise, Spitz (Spi), one of the ligands capable of
activating the EGFR signal is expressed throughout the cardiogenic
mesoderm in stage 11–13 embryos (Fig. 9B). However, the FGFR
ligands, Thisbe (Ths) and Pyramus (Pyr) are expressed in clusters of
ectodermal cells that appear in areas overlying the cardiogenic
mesoderm (Fig. 9D–E'; Stathopoulos et al., 2004; Klingseisen et al.,
2009; Kadam et al., 2009). This directional signal could be involved in
Fig. 5. Overlapping expression of Dl, L'sc and pMAPK in the cardiogenic mesoderm.
A: Map of the pattern of L'sc/pMAPK-positive mesodermal clusters of one segment
(adapted from Carmena et al., 1995). B–G: Three pairs of photographs (B, C; D, E; F, G)
show a lateral view of the mesoderm of two consecutive trunk segments. Upper panel
of each pair (B, D, F) represents early stage 11; lower panel (C, E, G) early to mid stage
12 (stage 12B). B and C show in situ hybridizations, with a probe against l'sc. In D and E,
a double labeling of anti-Dl (green) with anti-Phosphorylated MAP kinase (pMAPK,
red) is shown. Specimens shown in F and G were labeled with anti-Dl (grey). Note that
the dorsal clusters (C2 at stage 11; C14 and C16 at stage 12) that express l'sc (B, C) and
pMAPK (D, E) correspond to the anterior (a) and posterior (p) high-Dl clusters in the
cardiogenic mesoderm (F, G). A light blue circle represents the area where cluster C2 is
found (F). Dark blue circles represent areas where clusters C14 and C16 are located (G).
The purple circle represents the area where cluster C15 is located (G). Abbreviations: dt
dorsal tracheal branch; tp tracheal pit. Yellow bracket in D indicates spatial proximity
between dorsal tracheal branch and posterior high-Dl cluster (see also Fig. 3). Large
numbers in (A) identify the L'sc-positive mesodermal clusters; small numbers
underneath indicate number of cells per cluster. Bar: 20 μm (B–G).
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resulting in the eventual accumulation of higher MAPK activity
(followed by Dl expression) in the dorsal-most cells of the clusters
which will become cardioblasts.
Previous genetic studies had already shown that loss of pyr
resulted in a reduction of the Eve-positive cells derived from
mesodermal cluster C2 (Klingseisen et al., 2009; Kadam et al.,
2009). We conﬁrmed that the same mutation had signiﬁcantly
reduced numbers of pericardial nephrocytes and blood progenitors,
indicating that the Pyr-mediated signal plays a deﬁnitive role in
activating the MAPK pathway (Fig. 9E). By contrast, loss of ths, the
second FGFR ligand, did not result in any abnormalities in the
cardiogenic lineages (data not shown).Discussion
In this study we pursued two goals: to elucidate the precise
location and cellular composition of the cardiogenicmesoderm, and to
analyze the mechanism by which Notch becomes activated in the
restricted subset of these cells that become blood progenitors. Our
ﬁndings show that the cardiogenic mesoderm is comprised of
segmentally reiterated pairs of clusters (cardiogenic clusters) deﬁned
by high expression levels of Dl, L'sc and activated MAPK. The MAPK
pathway, activated through both EGFR and FGFR signaling, is required
for the speciﬁcation (EGFR) and maintenance (EGFR and FGFR) of all
cardiogenic lineages. As shown previously, the default fate of all
cardiogenic cells is cardioblasts (Hartenstein et al., 1992; Mandal
et al., 2004). Notch activity triggered by Dl is required for the
speciﬁcation of blood progenitors (thoracic cardiogenic clusters) and
nephrocytes (abdominal cardiogenic clusters), respectively. One of
the downstream effects of MAPK signaling is tomaintain high levels of
Dl in the cardiogenic clusters, and to help localize Dl expression
toward a dorsal subset of cells within these clusters, which will
become cardioblasts. Dl stimulates Notch activity in the surrounding
cells, which triggers the blood progenitor/nephrocyte fate in these
cells.
Cardiogenic and myogenic clusters: variations on a common theme in
Drosophila mesodermal development
The cardiogenic clusters form part of a larger population of
mesodermal cells deﬁned by high expression levels of l'sc (Carmena et
al., 1995). Based on l'sc in situ hybridization, these authors mapped 19
clusters of l'sc expressing cells within the somatic mesoderm. Many of
these clusters (called “myogenic clusters” in the following) give rise to
one or two cells that transiently maintain high levels of l'sc, whereas
the remaining cells within the cluster lose expression of l'sc. The l'sc-
positive cells segregate from the mesoderm to a more superﬁcial
position, closer to the ectoderm, undergo one ﬁnal mitotic division,
and differentiate as muscle founder cells (Carmena et al., 1995). Dl/
Notch mediated lateral inhibition was shown to act during the
singling-out of muscle founders from the myogenic clusters. Loss of
this signaling pathway caused high levels of L'sc to persist in all cells of
the myogenic clusters, with the result that all cells developed as
muscle founders. Interestingly, loss of l'sc had only a mild effect,
consisting of a slight reduction in muscle founders. This is similar to
what we ﬁnd in this paper in l'sc-deﬁcient embryos, which show only
a mild reduction in cardioblasts and other cardiogenic lineages.
The developmental fate of most of the L'sc-positive clusters within
the dorsal somatic mesoderm is different from that of the ventral and
lateral myogenic clusters discussed above, even though several
parallels concerning the morphogenesis, proliferation, and depen-
dence on Dl/Notch signaling are evident. The somatic (anterior, Wg-
positive) mesoderm is divided into a dorsal and ventral domain based
on the expression of Tin. Initially expressed at high levels in the entire
mesoderm, this gene is maintained only in the dorsal mesoderm, as a
result of Dpp signaling from the dorsal ectoderm. (Staehling-
Hampton et al., 1994; Frasch, 1995). The dorsal somatic mesoderm,
which we here call “early cardiogenic mesoderm,” includes four L'sc-
positive clusters, C2 and C14–C16. The development of C2 has been
described in detail by Carmena et al. (1998; 2002) and Buff et al.
(1998). C2 gives rise to a progenitor that divides twice; two of the
progeny become the Eve-positive pericardial cells. Meanwhile, C15
which appears later at the same position as C2, seems to behave like a
“normal”myogenic cluster. It produces a progenitor that divides once
and forms the founders of the dorsal muscle DA1. As shown in this
paper, the two remaining dorsal clusters, C14 and C16, give rise to the
cardioblasts. We note that the Eve-positive progenitors, as well as the
cardioblasts, resemble the muscle founders derived from the typical
myogenic clusters in three aspects. First, they segregate toward a
Fig. 6. Cardiogenic phenotypes in EGFR and FGFR pathway mutants. A–C: dorsal view of stage 16 embryos. Pericardial nephrocytes (pcn) and blood progenitors in the lymph gland
(lg) are labeled by anti-Odd (red) and anti-Pericardin (green); Pericardin labels odd positive pericardial nephrocytes as well as Seven-up (Svp) positive cardioblasts (cb). Sytox
(blue) labels all nuclei. In embryo where mesodermally expressedMef2-Gal4 drives an activated Ras construct (B), all cardiogenic cells, and in particular cells of the lymph gland and
pericardial nephrocytes, are strongly increased in number. The same phenotype results from driving a constitutively active FGF receptor (FGFR (htl); C). D, E: dorsal views of stage 16
embryos. Anti-Tinman (Tin; red) labels cardioblasts and Tin-positive pericardial cells (tpc) in wild type embryos (D). Cardioblasts that appear negative for Tin are the Svp positive
cardioblasts (D). In embryos carrying a null allele of the EGF receptor gene (EGFR; E), cardioblasts are absent. F: lateral view of stage 12 EGFR-mutant embryo. Labeling with anti-Dl
(green) and anti-Caspase 3 (Casp), a marker for apoptotic cell death. Note clusters of Casp-positive cells in dorsal mesoderm (large arrowheads). Small arrowheads point out
artefactual labeling of lumen of tracheae. G–I: lateral view of stage 13 embryos labeled with antibodies against Odd (red) and Dl (green). Note normal pattern of Odd-positive
pericardial nephrocytes, lymph gland, and epidermal stripes (ep) in wild-type embryo (G). Nephrocytes and lymph gland cells are strongly reduced in loss of function mutants for
both EGFR (H) and FGFR (Htl; I). J–L': lateral views of stage 11 embryos labeled with anti-Dl (green), anti-Mef2 (red) and Sytox (blue). Upper row (J–L) shows sections of cardiogenic
mesoderm, located more superﬁcially in the embryo (right underneath the ectoderm). Lower row (J'–L') represent section of deeper (more medial) mesoderm of same embryos as
shown in upper row, including (in wild type; J') the visceral mesoderm (vm), fat body mesoderm and somatic mesoderm (msfb/sm). Note strong expression of Dl and Mef2 in early
cardiogenic mesoderm (cme) of wild type embryo (J, J'). In an EGFR mutant (K, K'), the early cardiogenic mesoderm (based on Dl levels and number of Mef2-positive nuclei) is
strongly reduced or absent. In an FGFR (htl)mutant (L, L'), at this early stage, the cardiogenic mesoderm is still present, even though irregularities in the size and shape of cardiogenic
mesoderm clusters are apparent. Bars: 20 μm (A–F); 25 μm (G–L').
Fig. 7. Reduction in cardiogenic cell lineages in embryos deﬁcient for l'sc. A: dorsal view
of a stage 16 Df(1)scB57 (AS-C deﬁcient) embryo labeled with anti-Odd skipped (Odd;
red) and anti-Pericardin (green). Labeling of nuclei by Sytox (blue). Number of lymph
gland blood progenitors (lg) and pericardial nephrocytes (pcn) is signiﬁcantly reduced
(see histogram in B); cardioblasts are mildly reduced. Arrowhead in A points at wide
gap in row of pericardial nephrocytes. B: For all of following, two samples were counted
per organism. Lg (WT: n=8 lobes, mutant: n=4 lobes; p value: 4.85E-06); Pcn
(WT: n=6, mutant: n=7; values shown are for 4 hemisegments; p value: 3.34E-05);
Cb (WT: n=4, mutant: n=6; values shown are for 4 hemisegments; p value: 0.0197).
p Values calculated via Student t-test (1 tailed, equal variance). Bar: 20 μm.
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the cells within the clusters. Secondly, they undergo one (in case of
C2: two) rounds of division right after segregation. And third, they are
restricted in number by Dl/Notch signaling: in all cases, they are
increased in number following Dl or Notch loss of function.
Cardiogenic clusters, like myogenic clusters, also depend on the
MAPK signaling pathway. Past studies have shown that in the Eve-
positive C2 and C15 clusters, Ras, is capable of inducing the formation
of additional Eve-positive progenitors (Carmena et al., 2002). Ras is a
downstream activator of both the EGFR and FGFR tyrosine kinase
pathways, both of which have been seen to be important for the
formation of the Eve-positive progenitors. With a loss of the FGFR
pathway, Eve-positive progenitors of both the C2 and C15 cluster are
lost; by contrast, the EGFR pathway affects only C15. The balanced
activity of MAPK and Notch, which in part depends on reciprocal
interactions between these pathways, determines the correct number
of C2/C15 derived progenitors. Ras-induced MAPK activation upre-
gulates the expression of other MAPK signaling pathway members
Fig. 8. Expression and function of Wingless (Wg) in the cardiogenic mesoderm.
A: Dorsal view of stage 16 wg mutant embryo, labeled with anti-Odd-skipped (red),
anti-Pericardin (green), and Sytox (blue). All cardiogenic lineages are absent. B,
C: lateral views of stage 11 (B) and early-mid stage 12 (C) wild-type embryos labeled
with anti-Dl (green), and expressing a wg-lacZ reporter construct (Wg; red). Wg is
expressed in segmentally reiterated stripes that overlap with the early cardiogenic
mesoderm (cme in B). The wg reporter is expressed in all cells of the deﬁnitive
cardiogenic mesoderm (cmd), which, by this stage, has lengthened in the ap-axis, to
encompass the anterior and posterior high-Dl clusters (a, p). D, E: Lateral view of early
stage 12 wild-type (D) and wg mutant (E) embryo labeled with anti-Dl (green), anti-
L'sc (red), and Sytox (blue). Note anterior and posterior high-Dl clusters (a, p) of
deﬁnitive cardiogenic mesoderm, which also contain L'sc-positive cells in wild type (D).
Strongly Dl-positive cells ventrally adjacent to cardiogenic mesoderm are the emerging
dorsolateral trunks and dorsal branches of the tracheae (dlt). In a wg mutant (E), the
cardiogenic mesoderm is absent; the smooth epithelial layer dorsal of the Dl-positive
tracheal cells (dlt) corresponds to the dorsal ectoderm (dec), which in the absence of
dorsal mesoderm, folds far medially. F, F': Lateral view of early stage 12 wg mutant
embryo at a more superﬁcial (F) and a deeper (more medial) level (F'). Labeling is
with anti-Dl (green) and anti-Mef2 (red). Loss of Dl/Mef2 in (F) conﬁrms absence
of cardiogenic mesoderm. Other abbreviations: ep, epidermis; mg, midgut; tp
tracheal placodes; vec, ventral ectoderm; vm/fb, visceral mesoderm/fat body.
Bars: 20 μm (A–C); 20 μm (D–F').
Fig. 9. EGFR and FGFR ligands in the cardiogenic mesoderm. A–C: Lateral view of early
stage 12 embryos labeled with anti-EGFR (red in A; white in A') and anti-Delta antibody
(A; green), spitz-lacZ reporter (B; green), and FGFR (htl) reporter (C; green). All of these
are expressed widely in the cardiogenic mesoderm and beyond. Arrows in A and A'
point at Dl+cardiogenic clusters that upregulate EGFR. D: lateral view of early stage 11
embryo showing Pyramus (Pyr; blue) expression via in situ. Pyr is expressed in
segmental ectodermal clusters (Kadam et al., 2009) overlying the cardiogenic
mesoderm (white box outline). Figure adapted from Kadam et al., 2009. E, E': lateral
view of early stage 12 embryo at superﬁcial level of dorsal ectoderm (E) and level
medially adjacent to ectoderm, showing cardiogenic mesoderm (E'). Labeling with lacZ
reporter of Thisbe (Ths; green), the other FGFR (Htl) ligand. Mesoderm cells are labeled
by anti-Mef2 (red). Expression of Ths, similar to that of Pyr shown in D, occurs in cells
forming part of the dorsal-most row of the ectoderm, adjacent to underlying
cardiogenic mesoderm. F: Dorsal view of stage 16 embryo mutant for pyr, labeled
with anti-Odd skipped (red) and Sytox (blue). Note signiﬁcant reduction of lymph
gland cells (lg) and pericardial nephrocytes (pcn). Other abbreviations: cm, cardiogenic
mesoderm; tp, tracheal placodes. Bars: 20 μm (A–C); 20 μm (D–E).
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Argos, as well as Dl. Dl-activated Notch, in turn, inhibits MAPK
signaling.
We show here that both Dl/Notch andMAPK signaling are active in
the C14 and C16 clusters, which constitute the deﬁnitive cardiogenic
mesoderm. MAPK activity is required for the maintenance of all
lineages derived from these clusters, as shown most clearly in the
EGFR LOF phenotype that entails a lack of cardioblasts, blood
progenitors, and pericardial nephrocytes. Overexpression of Ras
results in an increased number of all three cell types, which indicates
that the C14/C16 clusters attain a larger size, possibly by an additional
round of mitosis. The phenotype seen in embryos suffering from loss-
or overexpression ofDl/Notch pathwaymembers can be interpreted in
the framework of a classical lateral-inhibition mechanism: Dl is
upregulated in the C14/C16 derived cardioblast progenitors (analo-
gous to the Eve-progenitors of C2/C15), from where it activates Notch
in the remainder of the C14/C16 cells; these cells are thereby inhibited
from forming cardioblasts, and instead become nephrocytes/blood
progenitors. The level of Notch activity affects the expression of tin
(low Notch) and the GATA homolog srp (high Notch), which triggers
the fate of cardioblasts and blood progenitors/nephrocytes, respec-
tively (Mandal et al., 2004).
MAPK is required for the initial activation of Dl in the cardiogenic
clusters (just as in the myogenic clusters). Input from the pathway is
most likely also instrumental in the subsequent restriction of Dl to the
cardioblast progenitors. The positive interaction between MAPK andNotch signaling could occur at several levels. A mechanism shown for
the ommatidial precursors of the eye disc involves Ebi and Strawberry
notch (Sno), which are thought to act downstream of EGFR signaling
and lead to an upregulation of Dl through the Su(H) and SMRTER
complex (Tsuda et al., 2002).
Generally, when one progenitor cell is seen to give rise to two
different cell types it is accomplished in one of twoways. One: there is
an asymmetric division, where a factor expressed by the progenitor is
segregated into only one daughter cell; two: a non-uniformly
expressed extrinsic signal effects one cell, but not its neighboring
sibling. Ward and Skeath (2000) had demonstrated that in the
posterior (abdominal) segments of the Drosophila cardiogenic
mesoderm, inhibition of Notch by Numb accounts for the asymmetric
activity of Notch in a small set of cardiogenic mesoderm cells, the Svp-
positive cells. If Numb function is removed, these cells, which
normally produce two cardioblasts and two pericardial nephrocytes,
instead give rise to four cardioblasts. However, multiple nephrocytes
per segment remain in numb loss-of-function mutations; further-
more, loss of numb does not cause any defect in the blood progenitors,
where asymmetrically dividing Svp-positive cells are absent. This
suggests that in addition to the numb-mediated mechanism,
directional activation of Notch by one of its ligands is required for
the majority of nephrocytes and all of the blood progenitors. We
propose here that the spatially restricted upregulation/maintenance
of Dl in nascent cardioblasts acts to activate Notch in the remainder of
the cells within each cardiogenic cluster, which promotes their fate as
blood progenitors and nephrocytes.
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The Notch signaling pathway is typically associated with members
of two different types of bHLH transcription factors. One type act as
activators, while the other act as repressors (Fisher and Caudy, 1998).
In the context of lateral inhibition, best studied in Drosophila
neurogenesis (Heitzler and Simpson, 1991; Campos-Ortega, 1993),
activating bHLH transcriptions factors, including genes of the AS-C
like l'sc, are expressed at an early stage in clusters of ectodermal or
mesodermal cells, where they activate genetic programs that promote
differentiative pathways such as neurogenesis, or myogenesis/
cardiogenesis (see above). Subsequently, Notch ligands initiate the
Notch pathway in these clusters; cells with high Notch activity turn on
members of the Hairy/E(spl) (HES) family of bHLH genes which act as
repressors and abrogate the transcriptional programs that had been
set in motion by the activating bHLH factors (Heitzler et al., 1996). As
shown in this paper, the gene cassette consisting of the Notch
signaling pathway, as well as activating and repressing bHLH factors,
operates in the cardiogenic mesoderm to determine the balance
between cardioblasts and blood progenitors/nephrocytes. As dis-
cussed in the following, the same cassette also appears to be centrally
involved in the speciﬁcation of vascular endothelial cells and
hematopoietic stem cells in vertebrates, which adds to the list of
profound similarities between Drosophila and vertebrate blood/
vascular development.
Even prior to the appearance of hemangioblasts, the lateral
mesoderm of vertebrates is prepatterned by sequentially activated
signaling pathways and transcriptional regulators similar to those
that act in ﬂies. The Wnt/Wg pathway, for example, separates
subdomains of the mesoderm in vertebrates and Drosophila, as well
as more ancestral ecdysozoans (Eriksson et al., 2009). Notch signaling
plays an essential role in generating boundaries between segmental,
as well as intra-segmental, subdomains within the ectoderm and
mesoderm (McGrew and Pourquie, 1998; Qiu et al., 2009; Tapanes-
Castillo and Baylies, 2004). The FGF signaling pathway predates the
appearance of Bilaterians and plays a highly conserved role in early
mesoderm patterning (Vasiliauskas and Stern, 2001; Wilson and
Leptin, 2000; Böttcher and Niehrs, 1995; Rebscher et al., 2009).
Likewise, speciﬁc sets of transcriptional regulators are the targets of
these signaling pathways (e.g., twist: Furlong, 2004; Vernon and
LaBonne, 2004; Yeo et al., 2009); zfh: Su et al., 1999; van Grunsven et
al., 2006; Kittelmann et al., 2009; myostatin: Lo and Frasch, 1999;
Artaza et al., 2005; Grade et al., 2009) and play a role during the
establishments of cell fate in the mesoderm. It appears, therefore, that
the bilaterian ancestor featured a mesodermal subdomain, the
“cardiogenic/lateral mesoderm,” in which signals of the Wg, BMP,
Notch, and FGF pathways and conserved sets of transcriptional
regulators established boundaries and cell fate in the mesoderm.
The vertebrate gene encoding an activating bHLH factor with
sequence similarity to the Drosophila AS-C genes is SCL (Begley et al.,
1989). SCL expression in the lateral mesoderm marks the ﬁrst
appearance of hemangioblasts (Gering et al., 1998; Davidson and
Zon, 2000; note that SCL is also expressed widely in the developing
vertebrate CNS; Van Eekelen et al., 2003). In Zebraﬁsh, from their site
of origin in the lateral mesoderm, SCL-positive hemangioblasts
migrate dorso-medially and form the intermediate cell mass (ICM).
The ICM is the site of primitive endothelial blood vessel and
hematopoietic cell speciﬁcation. Gain of function studies carried out
in zebraﬁsh embryos have shown SCL to be one of the genes important
in specifying the hemangioblast from the posterior lateral plate
mesoderm. The speciﬁcation of hemangioblast here comes at the
expense of other mesodermal cell fates, namely the somitic paraxial
mesoderm (Gering et al., 2003; Xiong, 2008; Gering and Patient, 2008;
Dooley et al. 2005). In mice, lack of SCL affects blood and vascular
development as SCL mutants are bloodless and show angiogenesisdefects in the yolk sac (Xiong 2008; Robb et al 1995; Shivdasani et al
1995; Visvader et al 1998).
Vertebrate homologs of the repressive Drosophila Hairy/E(spl)
family of bHLH genes are the Hes and Hey (hairy/Enhancer-of-split
related with YRPW motif) genes (Fischer and Gessler 2007; Iso et al.
2003; Kokubo et al. 1999; Satow et al. 2001; Leimeister et al. 1999,
2000; Steidl et al. 2000). A well studied member of the Hey family in
zebraﬁsh is gridlock, which is required for the speciﬁcation of
hematopoietic progenitors from the ICM. Hey 2 mutations in mice
lead to severe congenital heart defects (Fischer et al. 2007). In
addition, the Hes protein plays a role in hematopoiesis as it is a
positive regulator of Hematopoietic Stem Cell (HSC) expansion
(Kunisato et al. 2003).
Genetic studies of the Notch receptors and their ligands in
vertebrates support the idea that this pathway does indeed play a
crucial role in the initial determination of hematopoietic stem cells
(Bigas et al., 2010). The yolk sac and the para-aortic splanchnopleura
(P-Sp)/AGM (aorta gonad mesonephros) of Notch null mouse
embryos lack HSCs (Kumano et al 2003). A similar phenotype is
observed in mutants of Jagged 1, one of the Notch ligands (Robert-
Moreno et al., 2005, 2008). Notch is thought to be the deciding factor
between hematopoietic and endothelial cell fates when the two
originate from a common precursor or hemangioblast. In murine
mutants exhibiting lower Notch1 mRNA levels, a lack of hematopoi-
etic precursors is seen and is accompanied by an increase in the
number of cells expressing endothelial cell markers (Robert-Moreno
et al. 2005). Likewise, in Drosophila, loss of Notch is associated with an
increase in cardioblast number and a loss of blood precursor cells
(Mandal et al 2004).Acknowledgments
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